REVIEW
Accepted on 02 Jan 2026
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Inflammation, Immunity, and Cancer: New Pathways Towards Therapeutic Innovation
Inflammation, Immunity, and Cancer: New Pathways Towards Therapeutic Innovation
3,536
Total downloads
36k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 02 Jan 2026
Recent advances on Hippo-YAP pathway in skin diseases
doi 10.3389/fimmu.2025.1728064
- 394 views
ORIGINAL RESEARCH
Accepted on 30 Dec 2025
Paeoniflorin Attenuates Sepsis-Induced Liver Injury by Reprogramming Macrophage Polarization via the TLR4/NF-κB Pathway
- 135 views
ORIGINAL RESEARCH
Accepted on 29 Dec 2025
Single-cell and machine learning integration reveals OS-driven CCND1 promotes an aggressive phenotype in papillary thyroid carcinoma
ORIGINAL RESEARCH
Accepted on 26 Dec 2025
Berberine-Taxifolin Co-Administration Attenuates Inflammatory Response and Intestinal Barrier injury via NF-κB/NLRP3 Suppression in colitis
ORIGINAL RESEARCH
Accepted on 22 Dec 2025
Dahuang Gancao Dandelion Decoction regulates intestinal flora and inhibits NF-κB / ARA signaling pathway to alleviate ulcerative colitis
- 373 views
REVIEW
Accepted on 22 Dec 2025
Iron-Fueled Ferroptosis: A New Axis for Immunomodulation to Overcome Cancer Drug Resistance—From Immune Microenvironment Crosstalk to Therapeutic Translation
- 108 views
ORIGINAL RESEARCH
Accepted on 22 Dec 2025
CD71+ erythroid cells as a potential early biomarker for hemodynamic significant patent ductus arteriosus in preterm infants
REVIEW
Accepted on 17 Dec 2025
Current Update on Toll-like Receptor and Prostate Cancer: A Decade of Progress and Emerging Insights
- 137 views
SYSTEMATIC REVIEW
Accepted on 17 Dec 2025
Effects of Exercise on Angiogenesis Biomarkers in Cancer Patients: A Systematic Review and Meta-analysis
- 167 views
REVIEW
Published on 17 Dec 2025
The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny
doi 10.3389/fimmu.2025.1705051
- 534 views
ORIGINAL RESEARCH
Published on 16 Dec 2025
Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis
doi 10.3389/fimmu.2025.1728808
- 734 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Microbial Immunology
Inflammation
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: